Trial intelligence / Profile preview

Effect of Thyroid Replacement Therapy on Thyroid Structure in Subclinical Hypothyroidism

NCT04953195Phase 4Unknown

Sponsor
Beijing Chaoyang Hospital
Start
Jan 2019
Primary completion
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of levothyroxine sodium in hypothyroidism, sponsored by Beijing Chaoyang Hospital. Primary endpoints: Thyroid Stimulating Hormone at 12 weeks, Free Thyroxine at 12 weeks and 2 more. Status: unknown.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on NCT04953195.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04953195.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call